Showing results (71-80 of 84) with videos related to
Sort By:
Pageof 9
Journal of Experimental & Clinical Cancer Research : CR|August 21, 2022
Fisetin induces DNA double-strand break and interferes with the repair of radiation-induced damage to radiosensitize triple negative breast cancer cellsShayan Khozooei, Konstanze Lettau, Francesca Barletta, et al.Molecular Therapy. Oncology|April 30, 2026
Class I HDAC inhibition enhances the stem-like memory properties of CRISPR-engineered CAR T cells in neuroblastomaDan Cappabianca, Mahmoud Toulany, Seth Zima, et al.Stem Cells (Dayton, Ohio)|June 8, 2012
Targeting p90 ribosomal S6 kinase eliminates tumor-initiating cells by inactivating Y-box binding protein-1 in triple-negative breast cancersAnna L Stratford, Kristen Reipas, Kaiji Hu, et al.Oncotarget|July 19, 2018
Regulation of the interferon-gamma (IFN-γ) pathway by p63 and Δ133p53 isoform in different breast cancer subtypesSunali Y Mehta, Brianna C Morten, Jisha Antony, et al.Cancer Research|August 20, 2014
AXL mediates resistance to cetuximab therapyToni M Brand, Mari Iida, Andrew P Stein, et al.Journal of the National Cancer Institute|December 30, 2011
YB-1, the E2F pathway, and regulation of tumor cell growthAnnette Lasham, Weini Samuel, Helen Cao, et al.Molecular Diagnosis & Therapy|April 26, 2023
Dynamic ctDNA Mutational Complexity in Patients with Melanoma Receiving ImmunotherapySandra Fitzgerald, Cherie Blenkiron, Rosalie Stephens, et al.Scientific Reports|June 30, 2016
Pharmacological targeting of glucose-6-phosphate dehydrogenase in human erythrocytes by Bay 11-7082, parthenolide and dimethyl fumarateMehrdad Ghashghaeinia, Daniela Giustarini, Pavla Koralkova, et al.British Journal of Haematology|March 21, 2012
The impact of erythrocyte age on eryptosisMehrdad Ghashghaeinia, Judith C A Cluitmans, Ahmed Akel, et al.Cancers|October 2, 2020
Blocking Y-Box Binding Protein-1 through Simultaneous Targeting of PI3K and MAPK in Triple Negative Breast CancersAadhya Tiwari, Mari Iida, Corinna Kosnopfel, et al.Pageof 9